Pharma

Astellas, Takeda, RA Capital—Fierce Pharma Asia

Astellas CEO lays out the firm's new five-year plan. Takeda beats BMS in a psoriasis trial. RA provides China capabilities to its portfolio. And more.

Angus Liu Jun 12, 2026 8:23am

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS

Novo reports data breach, urges patients to 'remain vigilant'

Jun 11, 2026 1:18pm

Pharma marketers face privacy hurdles, turn to omnichannel strategies

Brought to you by Swoop

5 EU countries call for 'unity' in Europe's drug pricing approach

Jun 11, 2026 11:27am